HARPOON THERAPEUTICS INC - COM (HARP) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2024

Type / Class
Equity / COM
Symbol
HARP
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HARPOON THERAPEUTICS INC - COM (HARP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$21,138,740 0
2023 Q4 1,859,168 $21,138,740 +$16,287,657 $11.37 1
2023 Q3 628,804 $2,534,080 -$30,124,450 $4.03 2
2023 Q2 16,859,752 $11,966,921 -$386,524 $0.71 42
2023 Q1 17,401,069 $12,926,967 -$1,021,466 $0.74 42
2022 Q4 18,870,588 $13,693,158 -$2,495,445 $0.73 46
2022 Q3 21,679,868 $21,027,253 -$2,620,325 $0.97 42
2022 Q2 22,721,942 $43,399,623 -$8,091,594 $1.91 53
2022 Q1 25,231,728 $125,377,552 -$10,523,669 $4.97 72
2021 Q4 26,001,449 $196,242,684 +$2,247,655 $7.55 77
2021 Q3 25,801,876 $203,866,664 -$39,935,334 $7.90 86
2021 Q2 25,523,024 $353,884,691 +$16,487,075 $13.87 82
2021 Q1 26,882,413 $562,261,636 +$147,700,051 $20.92 87
2020 Q4 23,792,815 $395,190,805 -$4,834,225 $16.61 75
2020 Q3 20,076,294 $341,087,611 -$1,845,018 $16.99 78
2020 Q2 20,208,942 $335,469,590 +$18,785,962 $16.60 68
2020 Q1 19,274,272 $223,191,310 +$638,561 $11.58 50
2019 Q4 18,832,442 $278,531,579 +$7,510,744 $14.79 50
2019 Q3 14,322,426 $195,641,524 +$6,310,046 $13.66 42
2019 Q2 13,861,140 $180,194,448 +$4,129,847 $13.00 32
2019 Q1 13,189,006 $124,894,000 +$124,894,000 $9.47 27